By Peter A. McCullough, MD, MPH

A British High Court case filed by victims of blood clots caused by the AstraZeneca Oxford COVID-19 vaccine has the media buzzing over a company admission to a serious blood clotting condition called VITT or vaccine induced thrombocytopenic purpura.